The SELECT trial of nearly 18,000 individuals showed that 2.4mg of semaglutide reduced heart attacks, strokes, and mortality due to CVD, with 73% fewer patients progressing to diabetes compared to the control group
This is called chemotherapy-induced peripheral neuropathy (CIPN) (Brown 2019)
Moreover, a meta-analysis of cardiovascular outcomes in trials of GLP-1RAs has revealed cardiovascular benefits in T2D patients with or without pre-existing cardiovascular diseases [4]
We would say it is better suited to women who want a structured habit-building framework than those primarily seeking clinically tailored, female-specific medical oversight
Beck DE, Sweeney WB, McCarter MD
What are the main l carnitine uses